Luigi Xerri
Luigi Xerri publishes mostly in Molecular Medicine, Pharmacology and Molecular Biology, on topics such as Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy and Antibiotic Use and Resistance.
- World rank
- #4,634,482 of 7,710,434 ranked researchers
- Rank in United States
- #1,224,768 of 1,627,098
- Works
- 46
- Citations
- 861
- Citations per work
- 18.7
What does Luigi Xerri research?
Luigi Xerri's work is mostly in Biochemistry, Genetics and Molecular Biology (26%), Medicine (22%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1838.4%
- Life Sciences1533.6%
- Health Sciences1022.4%
- Medicine1022.4%
- Physical Sciences35.6%
- Chemistry35.6%
- 1Molecular Medicine18% of their works
- 2Pharmacology18% of their works
- 3Molecular Biology8% of their works
- 4Applied Microbiology and Biotechnology7% of their works
- 5Organic Chemistry6% of their works
- 6Epidemiology5% of their works
Research topics
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Use and Resistance
- Reproductive tract infections research
- Synthesis and biological activity
- Pharmaceutical and Antibiotic Environmental Impacts
- Escherichia coli research studies
- Phenothiazines and Benzothiazines Synthesis and Activities
Which keywords describe Luigi Xerri's research?
The keywords of their largest research topics: Antibiotic Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Antibiotic Pharmacokinetics, Critically Ill Patients, Antimicrobial Stewardship, Global Health and Antibiotics.
- Pathogenicity
- Biological Activities
- Sexually Transmitted Infections
- Medicinal Chemistry
- Antibiotics
- Antimicrobial Stewardship
- Antibiotic Pharmacokinetics
- ESKAPE Pathogens
- Antibiotic Resistance
- Multidrug-Resistant Bacteria
- Critically Ill Patients
- Global Health
- Heterocyclic Compounds
- Resistance Genes
- Vaginal Microbiome
- Escherichia coli
- Phenothiazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Antibiotic Resistance322 topics
- ESKAPE Pathogens231 topic
- Multidrug-Resistant Bacteria231 topic
- Antibiotic Pharmacokinetics201 topic
- Critically Ill Patients201 topic
- Antimicrobial Stewardship91 topic
- Global Health91 topic
- Antibiotics31 topic
- Heterocyclic Compounds31 topic
- Medicinal Chemistry31 topic
- Resistance Genes31 topic
- Sexually Transmitted Infections31 topic
- Vaginal Microbiome31 topic
- Biological Activities21 topic
- Escherichia coli21 topic
- Pathogenicity21 topic
- Phenothiazines21 topic
Where does Luigi Xerri work?
Luigi Xerri's main affiliation in the publication record is VenatoRx Pharmaceuticals (United States), United States.
How many publications and citations does Luigi Xerri have?
OpenAlex counts 46 works and 861 citations for Luigi Xerri, an h-index of 9, ranking #4,634,482 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Luigi Xerri. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.